Thus, we systematically explored candidate responsive biomarkers for PARPis based on genetic interactions by utilizing bioinformatics screening, and revealed that mutation of retinoblastoma tumor suppressor gene (RB1) is a candidate PARPi-sensitive biomarker for lung cancer (13). This evidence concerns the gene RB1 and lung carcinoma.